C57BL/6JCya-Pjvkem1/Cya
Common Name
Pjvk-KO
Product ID
S-KO-16360
Backgroud
C57BL/6JCya
Strain ID
KOCMP-381375-Pjvk-B6J-VB
When using this mouse strain in a publication, please cite “Pjvk-KO Mouse (Catalog S-KO-16360) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Pjvk-KO
Strain ID
KOCMP-381375-Pjvk-B6J-VB
Gene Name
Product ID
S-KO-16360
Gene Alias
Dfnb59, Gm1001
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 2
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000099986
NCBI RefSeq
NM_001080711.2
Target Region
Exon 2~3
Size of Effective Region
~1.9 kb
Overview of Gene Research
Pjvk, also known as DFNB59, encodes the pejvakin protein. Pejvakin is involved in generating auditory and neural signals in the inner ear [4]. Mutations in Pjvk are associated with autosomal recessive non-syndromic hearing impairment (AR-NSHI) and auditory neuropathy spectrum disorder (ANSD) [1].
Pathogenic variants in Pjvk cause the DFNB59 type of AR-NSHI, with phenotypes ranging from cochlear hearing loss to ANSD [1]. The numbers of reported cases and pathogenic variants are still small for accurate genotype-phenotype correlations [1]. In a study of Spanish familial AR-NSHI and simplex ANSD cases, four novel pathogenic variants were reported, expanding the spectrum of Pjvk mutations [1]. In Pjvk-mutant mice, gene therapy with the synthetic adeno-associated viral vector Anc80L65 restored spiral ganglion neuron density, hair cells in the cochlea, and vestibular ganglion neurons, improving sensorineural hearing impairment and balance function [2]. A transgenic mouse model carrying the c.874G > A (p.G292R) variant was generated to investigate the auditory and vestibular phenotypes of DFNB59 [3].
In conclusion, Pjvk plays a crucial role in auditory and neural signal generation in the inner ear. Mouse models, especially those with Pjvk mutations, have provided insights into the pathophysiology of Pjvk-related hearing impairments, highlighting the potential of gene therapy for treating these inner ear deficits [2].
References:
1. Domínguez-Ruiz, María, Rodríguez-Ballesteros, Montserrat, Gandía, Marta, Santarelli, Rosamaria, Del Castillo, Ignacio. 2022. Novel Pathogenic Variants in PJVK, the Gene Encoding Pejvakin, in Subjects with Autosomal Recessive Non-Syndromic Hearing Impairment and Auditory Neuropathy Spectrum Disorder. In Genes, 13, . doi:10.3390/genes13010149. https://pubmed.ncbi.nlm.nih.gov/35052489/
2. Lu, Ying-Chang, Tsai, Yi-Hsiu, Chan, Yen-Huei, Wu, Chen-Chi, Cheng, Yen-Fu. 2022. Gene therapy with a synthetic adeno-associated viral vector improves audiovestibular phenotypes in Pjvk-mutant mice. In JCI insight, 7, . doi:10.1172/jci.insight.152941. https://pubmed.ncbi.nlm.nih.gov/36278489/
3. Cheng, Yen-Fu, Tsai, Yi-Hsiu, Huang, Chun-Ying, Hsu, Chuan-Jen, Wu, Chen-Chi. 2020. Generation and pathological characterization of a transgenic mouse model carrying a missense PJVK mutation. In Biochemical and biophysical research communications, 532, 675-681. doi:10.1016/j.bbrc.2020.07.101. https://pubmed.ncbi.nlm.nih.gov/32917362/
4. Mujtaba, Ghulam, Bukhari, Ihtisham, Fatima, Amara, Naz, Sadaf. 2012. A p.C343S missense mutation in PJVK causes progressive hearing loss. In Gene, 504, 98-101. doi:10.1016/j.gene.2012.05.013. https://pubmed.ncbi.nlm.nih.gov/22617256/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
